Literature DB >> 10196476

Genomic organization of the human fibroblast growth factor receptor 2 (FGFR2) gene and comparative analysis of the human FGFR gene family.

Y Zhang1, M C Gorry, J C Post, G D Ehrlich.   

Abstract

The human fibroblast growth factor receptor (FGFR) genes play important roles in normal vertebrate development. Mutations in the human FGFR2 gene have been associated with many craniosynostotic syndromes and malformations, including Crouzon, Pfeiffer, Apert, Jackson-Weiss, Beare-Stevenson cutis gyrata, and Antley-Bixler syndromes, and Kleeblaatschadel (cloverleaf skull) deformity. The mutations identified to date are concentrated in the previously characterized region of FGFR2 that codes for the extracellular IgIII domain of the receptor protein. The search for mutations in other regions of the gene, however, has been hindered by lack of knowledge of the genomic structure. Using a combination of genomic library screening, long-range PCR, and genomic walking, we have characterized the genomic structure of nearly the entire human FGFR2 gene, including a delineation of the organization and size of all introns and exons and determination of the DNA sequences at the intron/exon boundaries. Comparative analysis of the human FGFR gene family reveals that the genomic organization of the FGFRs is relatively conserved. Moreover, alignment of the amino acid sequences shows that the four corresponding proteins share 46% identity overall, with up to 70% identity between individual pairs of FGFR proteins. However, the FGFR2 gene contains an additional exon not found in other members of the family, and it also has much larger intronic sequences throughout the gene. Remarkable similarities in genomic organization, intron/exon boundaries, and intron sizes are found between the human and mouse FGFR2 genes. Knowledge gained from this study of the human FGFR2 gene structure may prove useful in future screening studies designed to find additional mutations associated with craniosynostotic syndromes, and in understanding the molecular and cell biology of this receptor family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196476     DOI: 10.1016/s0378-1119(99)00047-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.

Authors:  Shih-hsin Kan; Navaratnam Elanko; David Johnson; Laura Cornejo-Roldan; Jackie Cook; Elsa W Reich; Susan Tomkins; Alain Verloes; Stephen R F Twigg; Sahan Rannan-Eliya; Donna M McDonald-McGinn; Elaine H Zackai; Steven A Wall; Maximilian Muenke; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2002-01-04       Impact factor: 11.025

2.  Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.

Authors:  David Barzan; Marlon R Veldwijk; Carsten Herskind; Yang Li; Bo Zhang; Elena Sperk; Wei-Dong Du; Xue-Jun Zhang; Frederik Wenz
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246

Review 3.  Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?

Authors:  Christine Heinzle; Zeynep Erdem; Jakob Paur; Bettina Grasl-Kraupp; Klaus Holzmann; Michael Grusch; Walter Berger; Brigitte Marian
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 4.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

5.  A case of Pfeiffer syndrome with c833_834GC>TG (Cys278Leu) mutation in the FGFR2 gene.

Authors:  Min Young Lee; Ga Won Jeon; Ji Mi Jung; Jong Beom Sin
Journal:  Korean J Pediatr       Date:  2010-07-31

6.  Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.

Authors:  Klaus Holzmann; Thomas Grunt; Christine Heinzle; Sandra Sampl; Heinrich Steinhoff; Nicole Reichmann; Miriam Kleiter; Marlene Hauck; Brigitte Marian
Journal:  J Nucleic Acids       Date:  2011-12-12

Review 7.  Angiogenesis-related pathways in the pathogenesis of ovarian cancer.

Authors:  Nikos G Gavalas; Michalis Liontos; Sofia-Paraskevi Trachana; Tina Bagratuni; Calliope Arapinis; Christine Liacos; Meletios A Dimopoulos; Aristotle Bamias
Journal:  Int J Mol Sci       Date:  2013-07-30       Impact factor: 5.923

8.  Tyrosine phosphorylation allows integration of multiple signaling inputs by IKKβ.

Authors:  April N Meyer; Kristine A Drafahl; Christopher W McAndrew; Jennifer E Gilda; Leandro H Gallo; Martin Haas; Laurence M Brill; Daniel J Donoghue
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 9.  Fibroblast Growth Factor Receptor Functions in Glioblastoma.

Authors:  Ana Jimenez-Pascual; Florian A Siebzehnrubl
Journal:  Cells       Date:  2019-07-13       Impact factor: 6.600

10.  The first Korean case of Beare-Stevenson syndrome with a Tyr375Cys mutation in the fibroblast growth factor receptor 2 gene.

Authors:  So-Hee Eun; Ki Ssu Ha; Bo-Kyung Je; Eung Seok Lee; Byung Min Choi; Jung Hwa Lee; Baik-Lin Eun; Kee Hwan Yoo
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.